EFFICACY AND SAFE USE OF SPECIFIC ANGIOTENSIN II RECEPTOR ANTAGONIST IRBESARTAN FOR CURING ARTERIAL HYPERTENSION IN CHILDREN AND TEENAGERS: A CLINICAL STUDY
A prolonged open non comparative study of efficacy and safety of various doses of specific angiotensin II (type at1) irbesartan for curing arterial hypertension in children and teenagers was carried out. The average irbesartan efficacy in Ag monotherapy in children was 92,5%, in the younger group ef...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2007-05-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1220 |